Perrigo (PRGO) Other Non-Current Assets (2013 - 2026)

Perrigo's (PRGO) quarterly Other Non-Current Assets came in at $264.6 million in Q1 2026, down 12.06% year-on-year from $300.9 million in Q1 2025, and down 2.93% on a QoQ basis from $272.6 million in Q4 2025.

Perrigo (PRGO) Other Non-Current Assets (2013 - 2026) Analysis & Trends

Perrigo (PRGO) has 14 years of Other Non-Current Assets data on file, last reported at $264.6 million in Q1 2026.

  • On a quarterly basis, Other Non-Current Assets fell 12.06% year-over-year to $264.6 million in Q1 2026; TTM through Mar 2026 was $264.6 million, a 12.06% decrease from a year earlier, with the FY2025 full-year figure at $272.6 million, down 14.44% from the prior year.
  • Other Non-Current Assets for Q1 2026 stood at $264.6 million, down from $272.6 million in the prior quarter.
  • Over the last five years, Other Non-Current Assets for PRGO reached as high as $541.5 million in Q4 2022 and fell as low as $264.6 million in Q1 2026.
  • Historically, Other Non-Current Assets has averaged $341.8 million across 5 years, with a median of $335.2 million in 2023.
  • On a YoY basis, Other Non-Current Assets climbed as much as 2183.85% in 2022 and fell as far as 80.44% in 2022.
  • Year by year, Other Non-Current Assets stood at $367.7 million in 2022, then slipped by 8.84% to $335.2 million in 2023, then declined by 4.95% to $318.6 million in 2024, then slipped by 14.44% to $272.6 million in 2025, then declined by 2.93% to $264.6 million in 2026.
  • Per Business Quant data, the three most recent Other Non-Current Assets figures were $264.6 million in Q1 2026, $272.6 million in Q4 2025, and $280.5 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 49.22 Mn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 1.79 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 351.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 491.06 Mn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 233.20 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 1.11 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 73.60 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 295.00 Mn
10 Perrigo 1.40 Bn 1.05 Bn 325.50 Mn 264.60 Mn

Historic Data

Download Data
DateValue
Mar 28, 2026 264.60 Mn
Dec 31, 2025 272.60 Mn
Sep 27, 2025 280.50 Mn
Jun 28, 2025 301.60 Mn
Mar 29, 2025 300.90 Mn
Dec 31, 2024 318.60 Mn
Sep 28, 2024 299.50 Mn
Jun 29, 2024 292.30 Mn
Mar 30, 2024 349.40 Mn
Dec 31, 2023 335.20 Mn
Sep 30, 2023 387.30 Mn
Jul 1, 2023 371.60 Mn
Apr 1, 2023 342.80 Mn
Dec 31, 2022 367.70 Mn
Oct 1, 2022 541.50 Mn
Jul 2, 2022 408.60 Mn
Apr 2, 2022 375.70 Mn
Dec 31, 2021 16.10 Mn
Jul 3, 2021 2.09 Bn
Dec 31, 2020 346.80 Mn